Related Experiment Video
Updated: Apr 12, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
All-trans retinoic acid suppresses topoisomerase IIα through the proteasomal pathway
Xiaoting Li1, Yuan Li, Xin Shen
1aDepartment of Nutrition and Food Safety, Nanjing Medical University bDepartment of Gynecology of the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract:
Topoisomerase IIα is a nuclear enzyme that alters DNA topology. It is a well-known anticancer target and related to cell differentiation status. All-trans retinoic acid (ATRA), an important active metabolite of vitamin A, is a promising anticancer agent in numerous malignancies. However, there are little data on the effect of retinoids on topoisomerase IIα regulation. In the present study, we investigated the relationship between ATRA and topoisomerase IIα, and the potential mechanisms of ATRA on topoisomerase IIα regulation. In several human carcinoma cell lines, ATRA was shown to suppress topoisomerase IIα protein, but not mRNA expression. ATRA induced the degradation of topoisomerase IIα through the proteasome pathway, but not the lysosome pathway. Ubiquitination was involved in this degradation. Western blot and immunocytochemistry proved that ATRA-induced topoisomerase IIα repression occurred only in the cell nuclei. ATRA not only influenced the cycle procession but also reduced the expression of cyclin D1. Cyclin D1, which is involved in cell differentiation, was regulated by topoisomerase IIα. Similar to cyclin D1, knockdown of topoisomerase IIα resulted in the increased differentiation of the cells, which was in contrast to the overexpression of topoisomerase IIα in the cells. Taken together, these data suggested that ATRA could target topoisomerase IIα and exert potential beneficial effects on cell differentiation.
Insights
All-trans retinoic acid (ATRA) suppresses the anticancer target topoisomerase IIα protein levels in carcinoma cells. This mechanism involves proteasomal degradation, promoting cell differentiation.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Topoisomerase IIα is a nuclear enzyme critical for DNA topology and cell differentiation.
- It is a recognized anticancer target, with limited data on retinoid regulation.
- All-trans retinoic acid (ATRA), a vitamin A metabolite, shows anticancer potential.
Purpose of the Study:
- To investigate the relationship between ATRA and topoisomerase IIα.
- To elucidate the mechanisms by which ATRA regulates topoisomerase IIα.
- To explore the impact of this regulation on cell differentiation.
Main Methods:
- Western blot and immunocytochemistry in human carcinoma cell lines.
- Analysis of protein and mRNA expression levels.
- Investigation of proteasome and lysosome degradation pathways.
- Ubiquitination assays and cyclin D1 expression analysis.
Main Results:
- ATRA suppressed topoisomerase IIα protein, not mRNA, in carcinoma cells.
- ATRA induced topoisomerase IIα degradation via the proteasome pathway, involving ubiquitination.
- Nuclear topoisomerase IIα repression by ATRA correlated with reduced cyclin D1 expression.
- Knockdown of topoisomerase IIα enhanced cell differentiation, opposing overexpression effects.
Conclusions:
- ATRA targets topoisomerase IIα for proteasomal degradation in cancer cells.
- This ATRA-induced repression of topoisomerase IIα influences cell cycle and differentiation.
- ATRA demonstrates potential anticancer benefits by modulating topoisomerase IIα and promoting cell differentiation.
More Related Videos
08:33Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
Published on: July 28, 2023
10:13Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Acne Infection
TGF - β Signaling Pathway
Inhibitors of Bacterial DNA Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...